Damian Curtis

BioConsortia appoints Damian Curtis to lead new gene editing and synthetic biology platform 

BioConsortia appoints Damian Curtis to lead new gene editing and synthetic biology platform 

Published on Aug 11th, 2020

BioConsortia, Inc., innovator of microbial solutions in crop protection, soil fertility, and yield improvement, welcomes Dr. Damian Curtis to the company as Director of Synthetic Biology and Genomics. He will lead new technology development in strain improvement and engineering for BioConsortia’s next generation of biopesticides, biostimulants and nitrogen fixation products. 

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.